Africa
Project Africa GRADIENT aims to gather and analyze pharmacogenetic data specific to African populations with funding from Novartis and GlaxoSmithKline.
Biden Cancer Moonshot Announces New Projects Focused on Decreasing Cancer Burden in Africa
Programs aim to improve screening tools and adherence, advance new point-of-care diagnostics, and increase access to precision medicine on the continent.
Biocartis, Merck KGaA Extend RAS Testing Partnership to Middle East, North Africa
The companies hope to improve access to biomarker testing to direct more personalized treatment for cancer patients in the region.
Merck, Daiichi Sankyo Begin Phase II/III Trial of R-DXd in Advanced Ovarian Cancer
Although patients aren't required to express CDH6 to be eligible, the drugmakers will measure biomarker expression levels as one of the trial's endpoints.
Guardant Health Reports Preliminary Q4, FY 2023 Revenue Growth, Inks Hikma Pharma Marketing Deal
The firm's estimated Q4 revenues were up about 21 percent and its full-year revenues rose 25 percent as it signed a new test marketing deal in the Middle East.